- Min.Order :1 Gram
- Purity: 98%min
- Payment Terms : T/T,,Other
Keywords
ACT129968 KYTH-105 biopharmaleader
Quick Details
- Appearance:solid
- Application:Lab research
- PackAge:as per customer's requiremnet
- ProductionCapacity:|Metric Ton|Day
- Storage:-20℃
- Transportation:as per customer's requiremnet
Superiority:
Have Kg scale in stock
Details:
Setipiprant (ACT-129,968, KYTH-105) is a drug acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2). It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients, it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View